Ocular Therapeutix (OCUL) Short Interest Ratio & Short Volume → Gold Mania (From Stansberry Research) (Ad) Free OCUL Stock Alerts $6.17 +0.30 (+5.11%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Ocular Therapeutix Short Interest DataCurrent Short Volume14,650,000 sharesPrevious Short Volume11,810,000 sharesChange Vs. Previous Month+24.05%Dollar Volume Sold Short$114.27 millionShort Interest Ratio / Days to Cover6.3Last Record DateApril 15, 2024Outstanding Shares154,726,000 sharesPercentage of Shares Shorted9.47%Today's Trading Volume4,640,306 sharesAverage Trading Volume2,279,850 sharesToday's Volume Vs. Average204% Short Selling Ocular Therapeutix ? Sign up to receive the latest short interest report for Ocular Therapeutix and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOCUL Short Interest Over TimeOCUL Days to Cover Over TimeOCUL Percentage of Float Shorted Over Time Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. Ocular Therapeutix Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202414,650,000 shares $114.27 million +24.1%N/A6.3 $7.80 3/31/202411,810,000 shares $107.47 million +28.9%N/A5.8 $9.10 3/15/20249,160,000 shares $86.65 million +93.3%N/A4.5 $9.46 2/29/20244,740,000 shares $47.68 million +19.4%N/A2.4 $10.06 2/15/20243,970,000 shares $27.23 million +0.3%N/A2.3 $6.86 1/31/20243,960,000 shares $19.25 million +18.2%N/A2.9 $4.86 Get the Latest News and Ratings for OCUL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocular Therapeutix and its competitors with MarketBeat's FREE daily newsletter. 1/15/20243,350,000 shares $14.71 million -23.5%N/A2.5 $4.39 12/31/20234,380,000 shares $19.53 million -3.5%N/A3.6 $4.46 12/15/20234,540,000 shares $17.84 million -14.0%N/A3.9 $3.93 11/30/20235,280,000 shares $13.09 million -9.1%7.0%5.9 $2.48 11/15/20235,810,000 shares $13.07 million +22.1%7.7%7.5 $2.25 10/31/20234,760,000 shares $13.57 million +9.4%6.3%6 $2.85 10/15/20234,350,000 shares $10.83 million +6.4%5.8%6.2 $2.49 9/30/20234,090,000 shares $12.84 million -1.7%5.4%5.7 $3.14 9/15/20234,160,000 shares $14.48 million +1.2%5.5%5.2 $3.48 8/31/20234,110,000 shares $15.54 million -16.5%5.5%3.8 $3.78 8/15/20234,920,000 shares $22.19 million -20.3%6.5%4.1 $4.51 7/31/20236,170,000 shares $28.01 million -8.2%N/A5.1 $4.54 7/15/20236,720,000 shares $32.05 million -1.2%N/A5.2 $4.77 6/30/20236,800,000 shares $35.09 million +4.3%N/A5.4 $5.16 6/15/20236,520,000 shares $32.40 million -2.0%N/A5.2 $4.97 5/31/20236,650,000 shares $42.56 million +20.3%N/A6.8 $6.40 5/15/20235,530,000 shares $35.00 million +14.3%N/A5.4 $6.33 4/30/20234,840,000 shares $30.01 million +13.4%N/A3.1 $6.20 4/15/20234,270,000 shares $22.46 million -7.2%N/A2.8 $5.26 3/31/20234,600,000 shares $24.24 million +2.7%N/A3.2 $5.27 3/15/20234,480,000 shares $22.85 million +12.6%N/A3.1 $5.10 2/28/20233,980,000 shares $24.04 million +27.2%N/A2.9 $6.04 2/15/20233,130,000 shares $19.06 million +6.5%4.1%2.4 $6.09 1/31/20232,940,000 shares $11.50 million +4.3%3.9%4.6 $3.91 1/15/20232,820,000 shares $11.28 million -5.1%N/A4.3 $4.00 12/30/20222,970,000 shares $8.35 million -2.3%N/A4.5 $2.81 12/15/20223,040,000 shares $8.42 million +4.1%N/A3.5 $2.77 11/30/20222,920,000 shares $8.67 million -0.3%N/A3.5 $2.97 11/15/20222,930,000 shares $9.43 million -12.0%N/A3.4 $3.22 10/31/20223,330,000 shares $12.02 million +2.2%N/A3.8 $3.61 10/15/20223,260,000 shares $13.43 million +9.4%N/A3.9 $4.12 9/30/20222,980,000 shares $12.37 million +2.4%N/A3.8 $4.15 9/15/20222,910,000 shares $18.07 million -12.1%N/A5.4 $6.21 8/31/20223,310,000 shares $16.81 million -1.5%N/A6.1 $5.08Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. OCUL Short Interest - Frequently Asked Questions What is Ocular Therapeutix's current short interest? Short interest is the volume of Ocular Therapeutix shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 14,650,000 shares of OCUL short. Learn More on Ocular Therapeutix's current short interest. What is a good short interest ratio for Ocular Therapeutix? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OCUL shares currently have a short interest ratio of 6.0. Learn More on Ocular Therapeutix's short interest ratio. Is Ocular Therapeutix's short interest increasing or decreasing? Ocular Therapeutix saw a increase in short interest in April. As of April 15th, there was short interest totaling 14,650,000 shares, an increase of 24.0% from the previous total of 11,810,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ocular Therapeutix's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Ocular Therapeutix: Aurinia Pharmaceuticals Inc. (8.91%), Praxis Precision Medicines, Inc. (4.69%), PureTech Health plc (0.02%), Pliant Therapeutics, Inc. (12.63%), Bicycle Therapeutics plc (9.85%), Longboard Pharmaceuticals, Inc. (14.81%), Arcturus Therapeutics Holdings Inc. (18.77%), Evolus, Inc. (9.57%), Zentalis Pharmaceuticals, Inc. (23.43%), Phibro Animal Health Co. (3.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Ocular Therapeutix stock? Short selling OCUL is an investing strategy that aims to generate trading profit from Ocular Therapeutix as its price is falling. OCUL shares are trading up $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ocular Therapeutix? A short squeeze for Ocular Therapeutix occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OCUL, which in turn drives the price of the stock up even further. How often is Ocular Therapeutix's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCUL, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Aurinia Pharmaceuticals Short Interest Data Praxis Precision Medicines Short Interest Data PureTech Health Short Interest Data Pliant Therapeutics Short Interest Data Bicycle Therapeutics Short Interest Data Longboard Pharmaceuticals Short Interest Data Arcturus Therapeutics Short Interest Data Evolus Short Interest Data Zentalis Pharmaceuticals Short Interest Data Phibro Animal Health Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OCUL) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024Altimetry